E
Esperion Therapeutics, Inc. (ESPR)
NGM – Real vaqt narxi. Valyuta: USD
3.17
+0.02 (0.63%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
3.16
-0.01 (-0.32%)
Bozordan keyin: Jun 26, 2026, 7:17 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
3.17
+0.02 (0.63%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
3.16
-0.01 (-0.32%)
Bozordan keyin: Jun 26, 2026, 7:17 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Umumiy qarz $543.8M naqd pul zahiralaridan ($156.2M) sezilarli darajada ko'p bo'lib, moliyaviy barqarorlik xavotirlarini keltirib chiqaradi
Jami joriy aktivlar $459.5M jami joriy majburiyatlardan $300.4M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (-1.8) tarmoq o'rtachasidan (-0.8) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz qoplash koeffitsiyenti (-0.3x) xavfli darajada past bo'lib, qarzni qaytarish xavflarini ko'rsatadi
Salbiy erkin pul oqimi -$27.9M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 1.53 | 2.52 | 8.0 | |
| Tezkor likvidlik nisbati | 1.18 | 1.78 | 7.0 | |
| Qarz/Kapital nisbati | N/A | -0.80 | 1.0 | |
| Qarz/Aktivlar nisbati | 1.18 | 0.73 | 1.0 | |
| Foiz to‘lov qoplami | -0.33 | -13.90 | 1.0 | |
| O‘rtacha ball | 3.6 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 75M | 116M | 332M | 403M | 418M |
| Yalpi foyda | 48M | 73M | 264M | 274M | 286M |
| Operatsion daromad | -180M | -156M | 54M | 60M | 76M |
| Sof foyda | -234M | -209M | -52M | -23M | -7M |
| EBITDA | -179M | -155M | 54M | 60M | 76M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 12.25 | 92.86 | 8.5 |
| Keyingi chorak | 13.05 | 100.89 | 9.0 |
| Joriy yil | -3.85 | 63.64 | 5.5 |
| Keyingi yil | 15.79 | 779.17 | 9.5 |
| O‘rtacha ball | 8.1 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | -52.44 | -140.74 | -145.44 | -161.68 | 1.0 |
| Yil/Yil | 23.25 | 37.72 | 52.38 | 7.36 | 8.8 |
| 3 yil o‘rtacha | 87.04 | 47.3 | 63.08 | 50.06 | 10 |
| 5 yil o‘rtacha | 38.36 | 13.52 | 34.69 | -4.52 | 7.3 |
| O‘rtacha ball | 6.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |